- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT00589498
Fat Gain and Cardiovascular Disease Mechanisms
Understanding the mechanisms of obesity-induced hypertension is important both for prevention and therapy. Studies of patients with established obesity have provided valuable information on pathophysiologic links between obesity and both blood pressure and cardiovascular risk. However, these studies are necessarily limited by the heterogeneity of obesity-associated disease so that the relative contribution of obesity or hypertension or other co-existing diseases to specific regulatory abnormalities is often not clear. Clarification of whether any abnormalities associated with increased cardiovascular risk were present before or after the development of obesity has also been problematic.
We therefore propose a series of novel studies directed at establishing the effects of increased body fat in otherwise healthy individuals. We will determine the distribution patterns of increased body fat and how both increased body fat and fat distribution relate to changes in blood pressure, and in neural, endothelial and inflammatory mechanisms which have been implicated in the development and progression of cardiac and vascular disease.
We will study non-obese subjects with and without a family history of hypertension. These subjects will undergo an eight-week program of overfeeding with the objective of inducing a 4 kg fat gain. We will determine the nature of fat distribution in these individuals after the fat gain program and subsequently after an eight-week period of weight loss and restoration of normal body weight. Measurements will be compared to those obtained in a matched control group with and without a family history of hypertension, who will continue their normal diets. We will test the following hypotheses:
- Individuals with a family history of hypertension will gain more visceral fat and upper body subcutaneous fat and will have greater blood pressure increases with overfeeding- compared with those without such a family history.
- For all overfed subjects, increases in blood pressure and insulin resistance with fat gain will be most marked in those individuals with a predominantly upper body and visceral fat accumulation.
- Upper body and visceral fat gain will also be associated with greater impairment in cardiovascular function, higher nocturnal blood pressures and an increased likelihood of sleep disordered breathing.
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Studietype
Registrering (Faktiske)
Fase
- Fase 3
Kontakter og plasseringer
Studiesteder
-
-
Minnesota
-
Rochester, Minnesota, Forente stater, 55905
- Mayo Clinic
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- We will enroll up to 180 subject in order to fulfill screening requirements and have complete studies in 120 total (60 with and 60 without family history hypertension).
- Gender: Male and female.
- Ages: 18 to 40 (inclusive).
Exclusion Criteria:
- Body-mass index > 33 kg/m2
- Tobacco smoking or chewing
- Shift worker
- Any diseases
- Any prescription medications (except, oral contraceptives are permitted)
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Forebygging
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Enkelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
---|---|
Eksperimentell: 1
Subjects who are randomized to overfeed will visit with the General Clinical Research Center dieticians as often as necessary to gain 2 kg of fat (about 4 kg overall) over a period of 8 weeks.
|
Each subject received 1000 kcal/d in addition to weight maintenance requirements.
The diet composition throughout the study was 40% carbohydrate, 40% fat, and 20% protein.
|
Ingen inngripen: 2
Subjects who are randomized to non-overfeeding will continue with their normal diet and activity levels for a period of 8 weeks.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tidsramme |
---|---|
Individuals with a family history of hypertension will gain more visceral fat and upper body subcutaneous fat and will have greater blood pressure increases with overfeeding- compared with those without such a family history.
Tidsramme: conclude the 180 patients recruited
|
conclude the 180 patients recruited
|
Sekundære resultatmål
Resultatmål |
Tidsramme |
---|---|
* For all overfed subjects, increases in blood pressure and insulin resistance with fat gain will be most marked in those individuals with a predominantly upper body and visceral fat accumulation.
Tidsramme: after recruiting at least 70 patients
|
after recruiting at least 70 patients
|
Upper body and visceral fat gain will also be associated with greater impairment in cardiovascular function, higher nocturnal blood pressures and an increased likelihood of sleep disordered breathing
Tidsramme: Recruit at least 70 subjects
|
Recruit at least 70 subjects
|
Increased weight gain, particularly in the upper body and visceral regions, will be accompanied by enhanced production of inflammatory mediators linked to cardiovascular risk, including adhesion molecules and C-reactive protein.
Tidsramme: Recruit at least 70 patients
|
Recruit at least 70 patients
|
These changes will resolve with subsequent loss of weight at the end of the overfeeding program and restoration of normal body fat and fat distribution.
Tidsramme: Recruit at least 70 patients
|
Recruit at least 70 patients
|
Samarbeidspartnere og etterforskere
Sponsor
Samarbeidspartnere
Publikasjoner og nyttige lenker
Hjelpsomme linker
Studierekorddatoer
Studer hoveddatoer
Studiestart
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Anslag)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Anslag)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- 652-03
- NIH HL-073211
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Søvnapné syndromer
-
University of Wisconsin, MadisonPhilips HealthcareFullførtSøvn, Slow-wave Sleep, Sleep Enhancement, Sleep Optimization
-
National University of SingaporeRekrutteringReduksjon av skjermbruk + Sleep Extension | FrilevendeSingapore
-
Brigham and Women's HospitalAktiv, ikke rekrutterendeSøvnforstyrrelser, iboende | Søvnforstyrrelser, døgnrytme | Advanced Sleep Phase Syndrome (ASPS) | Forsinket søvnfasesyndrom | Skift-arbeid søvnforstyrrelse | Forsinket søvnfase | Ikke-24 timers søvn- og våkneforstyrrelse | Advanced Sleep Phase Syndrome | Avansert søvnfase | Uregelmessig søvn-våkne-syndrom | Skift...Forente stater
-
Brigham and Women's HospitalCharite University, Berlin, Germany; Stanford UniversityRekrutteringSøvnforstyrrelser, iboende | Søvnvåkenforstyrrelser | Søvnforstyrrelser, døgnrytme | Advanced Sleep Phase Syndrome (ASPS) | Forsinket søvnfasesyndrom | Skift-arbeid søvnforstyrrelse | Forsinket søvnfase | Ikke-24 timers søvn- og våkneforstyrrelse | Advanced Sleep Phase Syndrome | Avansert søvnfase | Uregelmessig... og andre forholdForente stater
-
Tyco Healthcare GroupUkjent
-
Northwell HealthJazz PharmaceuticalsRekrutteringElektrisk status Epilepticus of Slow-Wave SleepForente stater
-
Maastricht University Medical CenterEpilepsiecentrum KempenhaegheFullførtRolandsk epilepsi | Landau-Kleffners syndrom | Nattlig frontallappepilepsi | Elektrisk status Epilepticus under Slow Wave SleepNederland
-
Brigham and Women's HospitalStanford UniversityRekrutteringSøvnvåkenforstyrrelser | Søvnforstyrrelse | Søvnforstyrrelser, døgnrytme | Døgnrytmeforstyrrelser | Døgnrytme søvnforstyrrelse | Advanced Sleep Phase Syndrome (ASPS) | Forsinket søvnfasesyndromForente stater
-
Assistance Publique - Hôpitaux de ParisRekrutteringIntensivavdelingens syndrom | Pediatrisk postintensiv syndromFrankrike
-
Brian JonasNational Cancer Institute (NCI); Celgene; Pharmacyclics LLC.FullførtTidligere behandlet myelodysplastisk syndrom | Myelodysplastisk syndrom | Terapierelatert myelodysplastisk syndrom | Sekundært myelodysplastisk syndrom | Refraktært høyrisiko myelodysplastisk syndromForente stater
Kliniske studier på 1000 extra calories
-
Vyaire MedicalHar ikke rekruttert ennåVentilasjonsterapi; Komplikasjoner
-
University of California, IrvineFullførtCerebral iskemiForente stater
-
NeuroEM Therapeutics, Inc.University of South Florida Health / Byrd Alzheimer's InstituteUkjentAlzheimers sykdom | Alzheimers sykdom, sent debutForente stater
-
HeadSense MedicalRigshospitalet, DenmarkUkjentIntrakraniell hypertensjonDanmark, Tyskland, Nederland
-
HeadSense MedicalState Medical Center, Republic of ArmeniaFullført
-
TaiGen Biotechnology Co., Ltd.R&G Pharma Studies Co.,Ltd.Fullført
-
HeadSense MedicalUniversity of Maryland, College ParkUkjentHjernehinneblødning | Vasospasme, intrakraniellForente stater
-
HeadSense MedicalSuspendertSlag | Hjerneskader | Neoplasmer i hjernen | Intrakraniell hypertensjon | HydrocephalusJapan
-
HeadSense MedicalElisabeth-TweeSteden ZiekenhuisFullførtHjerneskader | Intrakraniell hypertensjonNederland